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Bertolotti’s syndromeAbstract Aim of the work: To assess the clinical characteristics and evolutionary track of
Bertolotti’s syndrome in the rheumatology department of the National Teaching Hospital Hubert
Koutoukou Maga of Cotonou, Benin.
Patients and methods: A prospective study of 3 years (January 2011 to December 2013) evaluat-
ing the young patients suffering from Bertolotti’s syndrome met in the rheumatology department in
NHU of Cotonou. Patients with the syndrome were recruited and followed-up over the study per-
iod. The clinical characteristics and therapeutic outcome of the patients were assessed over a period
of six months.
Results: Of 2048 patients seen during the period in the rheumatology department, 21 (1%) had
Bertolotti’s syndrome. The male:female ratio of the patients was 0.6 and the average age was
25.74 ± 9.32 [19–35] years. Three patients came from the neighbouring countries (one from Togo
and two from Nigeria). The average disease duration was 541 ± 113 [180–656] days. The clinical
symptom was dominated by low back and buttock pains (15 cases). In seven cases, there was S1
nerve root pain. Tenderness over the lumbo-sacral junction and spine was the main sign on physical
examination. The evolution was satisfactory with a decline in pain and need for analgesics and
NSAIDs after six months in 7 cases while a corticosteroid inﬁltration under ﬂuoroscopy was
required in 14 patients.
Conclusion: Bertolotti’s syndrome should be considered as a separate entity in the differential
diagnosis of mechanical low back pain in young patients. Good knowledge of this syndrome could
contribute to improved management of low back pain.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Bertolotti’s syndrome, described in 1917, refers to the occur-
rence of lower back or buttock pain induced by the presence
of a transverse process of the mega-mobile last vertebra which
Table 1 Clinical symptoms in the patients with Bertolotti’s
syndrome.
N (%)
Lateralized LBP 8 (38)
Low back/buttock pain 5 (23)
Ipsilateral buttock pain 1 (6)
Sciatica 7 (33)
Neurologic deﬁcit 0 (0)
94 M. Avimadje` et al.contacts the sacrum and/or in the iliac wing sometimes form-
ing an equivalent joint space (sometimes called overly ‘‘third
sacroiliac’’) [1]. It affects 5–7% of the population and is found
in 10% of low back pain patients aged less than 30 years [2,3].
Several cases have been reported in the Western literature
review [3–11]. African literature on this syndrome is poor
[12] probably related to a lack of literature on this subject.
The objective of this study is to clarify the clinical charac-
teristics of Bertolotti’s syndrome and to assess the therapeutic
management in the rheumatology department of an underde-
veloped country like Benin.
2. Patients and methods
This is a prospective study including patients in the rheumatol-
ogy department of the National Teaching Hospital ‘‘Hubert
Koutoukou Maga’’ of Cotonou followed-up for lumbo-sacral
buttock pain ‘pygalgia’ with a mega-L5 transverse process.
The patients regularly following-up in the rheumatology
department of CNHU-HKM (Cotonou) were recruited over
a period of 3 years, from January 2011 to December 2013
through the following criteria: Age between 18 and 35 years;
clinically presenting with lumbago, pygalgia or lower back or
buttock pain isolated or associated with radiation along the
S1 nerve root; having an anteroposterior plain radiograph of
the lumbar spine showing a mega-apophysis of L5 with sacro-
iliac neo joint-related clinical symptoms and received the pre-
scribed therapeutic.
Patients with painful symptoms associated with another
obvious aetiology were not included in the study. The study
was approved by the local ethics committee and conforms to
the 1995 Helsinki declaration. All patients gave their informed
consent prior to their inclusion.
The demographic parameters (age, gender), disease dura-
tion, the clinical symptoms, treatment and scalable data were
collected with a structured sheet survey.
Analgesics used were those of levels I (paracetamol) and II
(paracetamol or tramadol in combination with codeine or
caffeine) for a period of 15 days and maintained on demand
throughout the duration of the study. Non-Steroidal
Anti-Inﬂammatory Drugs (NSAIDs) (diclofenac, ketoprofen
and celecoxib) were used at a maximum dose for 15 days.
No NSAIDs were given later. In cases with severe pain, ﬂuo-
roscopy guided injections were considered.
The visual analogue scale (VAS) of pain of the patients was
evaluated at the 3rd and 6th months. The primary criterion
was the reduction in the VAS.
Statistical analysis: Data were analysed using the Ofﬁce




Out of 2048 patients seen during the period of the study, 21
(1%) had Bertolotti’s syndrome. The syndrome represented
2.8% of LBP outpatients. The sex (male: female) ratio was
0.6. The average age of patients was 25.74 ± 9.32 [19–35]
years. Three patients came from the neighbouring countries
(one from Togo and two from Nigeria).3.2. Clinical features
The patients’ clinical presentation was essentially unilateral (20
cases) with average disease duration of 541 ± 113 [180–656]
days. The clinical symptom was represented by low back pain
and lumbar-buttock pain. There was an ipsilateral radiation
along S1 with musculoskeletal injury in 7 patients (Table 1).
Tenderness over the para-spinal muscles next to the lumbo-
sacral junction and painful extension of the spine were the main
physical examination signs present in all patients. The plain
radiograph of the lumbar spine showed a mega-apophysis of
L5 with the sacroiliac joint. (Figs. 1 and 2).
3.3. Therapeutic data
Apart from the analgesics and NSAIDs used by almost all
patients, 67% have used a series of 3 ﬂuoroscopy guided injec-
tions (one week apart) of cortivazol for pain relief (Fig. 3).
Table 2 summarizes the therapeutic data (see Table 3).
3.4. Outcome
The evolution was satisfactory in 14 patients with a decline of
pain after six months (residual pain less than 50% and a total
absence of drug consumption). Three patients had continuous
pain (despite a series of 3 ﬂuoroscopy guided injections). Four
patients had a relapse after 6 months which required a repeat
of inﬁltration series.
4. Discussion
Bertolotti’s syndrome is a mega-transverse process of the last
lumbar vertebra provoking a neo-articulation with the sacrum
and the ilium. It is a syndrome that is not an uncommon cause
of back pain in young adults and may be a source of chronic
pain in 10% of LBP patients younger than 30 years [4,5,12].
The hospital frequency of this pathology and the young age
of the patients observed in our study attest to the cosmopolitan
character of this syndrome in young adults.
On the pathophysiological level, two mechanisms have been
proposed to explain the pain. The work teams Pekindil et al.
[13] and Connoly and coworkers [14] suggest a direct mecha-
nism related to the suffering of neo-articulation detected by
SPECT-CT in symptomatic patients. On the other hand, other
studies such as those of Luoma et al. [15], Bron et al. [16] and
Aihara and associates [17] suggest a rather indirect mechanism
by premature wear of the L4–L5 disc due to improper locking
of the iliolumbar ligaments.
Figure 1 Right mega-apophysis of L5 forming a new transverse
iliac joint in a 24 year old student.
Figure 2 Bilateral Bertolotti’s syndrome in a 28 year old banker.
Figure 3 Inﬁltration under ﬂuoroscopy of the Bertolotti’s
syndrome in a 29-year old female computer science specialist.




Non Steroidal Anti-Inﬂammatory Drugs 20 (95)
Short term oral corticosteroids 2 (9.5)
Fluoroscopy guided corticosteroid injections 14 (67)
Surgery 0 (0)
Table 3 Outcome in patients with Bertolotti’s syndrome.
Residual pain <50% P50%
N (%) N (%)
After 3 months 18 (85.7) 3 (14.3)
After 6 months 14 (66.7) 7 (33.3)
Bertolotti’s syndrome 95Clinically, all of our patients had LBP or lumbar-buttock
pain. The symptoms may be clinically presented as a sacroiliac
disease [18]. In the present study, pseudo-root involvement was
present in one third of cases in contrast to the series of Avi-
madje et al. [2], where two-thirds of their patients had sciatica.
Shibayama et al. suggested that sciatica syndrome may result
from extra-foraminal nerve compression caused by the
enlarged transverse process [19].
Inﬁltration under ﬂuoroscopy of cortivazol was given to the
majority of patients in our series with a pain reduction of morethan 50% in more than half of all patients after six months.
This is in agreement with the study of Avimadje` et al. [2] in
96 M. Avimadje` et al.France where inﬁltration was the main treatment used. A
literature review revealed that surgery is often used for the
treatment of this condition especially in refractory cases to
medical treatment. It is often excisions of the mega- apophysis
or arthrodesis with questionable efﬁcacy [20–22].
Proposed in the 3 cases in our series with continuous non
declining pain after one month, surgery could not be done
due to lack of ﬁnancial resources and fear to undergo spine
surgery. Moreover, Delisser and Burducea proposed a radio-
frequency treatment to enhance the beneﬁcial effect of inﬁltra-
tion [23].
In conclusion, Bertolotti’s syndrome should be considered
as a separate entity in the differential diagnosis of mechanical
low back pain in young patients. Its diagnosis is based on the
simple presence of a transverse mega-process of the last lumbar
vertebra, which articulates with the sacrum and/or iliac wing
forming the source of pain. However, the diagnosis is done
by exclusion after ruling out all other causes of back pain.
The number of cases reported in our series shows the impor-
tance of this syndrome in Benin and West African countries.
Inﬁltration of corticosteroids under ﬂuoroscopy remains an
effective treatment for the management of this syndrome.
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